FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Doceree Closes $11 Million Series A Funding
Doceree reports the financing accelerates company's global growth and development of its platform to enrich HCP messaging solutions on endemic and point-of-care networks for life sciences companies.
Aspen Surgical Products Receives Additional Investment from Audax Private Equity
Aspen Surgical Products CEO Jason Krieser said, "This transaction represents an excellent return for our original investors, while empowering our Aspen Surgical organization to continue to progress in our mission of improving safety and efficiency for clinicians at an even faster rate.”
CardioRenal Raises €3.3 Mil
CardioRenal advises the funds will enable the company to complete the process of obtaining regulatory approval for its connected medical device.
Osso VR Raises $66 Million
Ossor VR will use the funds to broaden access to surgical education for healthcare professionals.
Podimetrics Secures $45 Million Series C
Podimetrics said existing investors include, Polaris Partners and Scientific Health Development, also participated in the financing.
Toetal Solutions Raises $1.02 Million in New Financing
Toetal Solutions notes that the proceeds from the funding will enable Toetal to rapidly scale the development of its flagship product, the Ziptoe™ Hammertoe System.
Rehabtronics Receives $1.25 Million from Genome BC
Rehabtronics notes the funds will facilitate free 90-day quality improvement trials of Prelivia at qualified healthcare facilities in the United States.
Scinvivo Secures 1 Mil Investment for In Human Clinical Trials & CE
Marijn van Os, CEO of Scinvivo: “With this investment, we will make the first steps in the clinics and show the incredibly high-resolution tissue images captured with our platform.”
OSF Ventures Joins Early Financing for 1st FDA-cleared Wireless Seizure Detection Sensor
Catalyst Health Ventures (CHV) and Genoa Ventures co-led the over-subscribed early financing along with participation from Dexcom, Inc. (DXCM), Wavemaker 360, and existing investors MedMountain Ventures and Salt Lake City Angels.
Medical Device News Magazine
